Perimeter Medical Imaging AI 5/13/2026 Earnings Report

Perimeter Medical Imaging AI EPS Results

• Actual EPS: N/A
• Consensus EPS: -$0.03
• Beat/Miss: N/A
• One Year Ago EPS: N/A

Perimeter Medical Imaging AI Revenue Results

• Actual Revenue: N/A
• Expected Revenue: $1.02 million
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

Perimeter Medical Imaging AI Announcement Details

• Date: 5/13/2026
• Time: N/A
• Conference Call Date: N/A
• Conference Call Time: N/A

Perimeter Medical Imaging AI (OTCMKTS:PYNKF) is a developer of real-time intraoperative margin assessment solutions for surgical oncology. The company’s flagship OTIS™ system combines high-resolution optical coherence tomography (OCT) hardware with proprietary AI-driven image analysis to deliver detailed, volumetric scans of excised tissue. By providing surgeons with immediate feedback on tissue margins, Perimeter’s platform aims to reduce re-excisions and improve patient outcomes in breast and other solid tumor surgeries.

At the heart of Perimeter’s offering is its MarginAI™ software, which leverages deep learning algorithms trained on extensive tissue image databases to automatically detect residual tumor presence within minutes. The OCT component captures micron-level structural detail without requiring staining or sectioning, while the AI layer highlights areas of concern directly on the three-dimensional scan. This integration is designed to fit seamlessly into existing surgical and pathology workflows, enabling rapid decision-making at the point of care.

Founded as a spin-out from research groups at the University of Waterloo, Perimeter is headquartered in Waterloo, Ontario, and conducts clinical collaborations and pilot programs across North America. The company has pursued regulatory clearances from the U.S. Food and Drug Administration and is engaged with Health Canada for licensing. Through partnerships with leading cancer centers, Perimeter continues to refine its technology and expand its footprint in image-guided surgical oncology.